GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Effective Interest Rate on Debt %

American Cryostem (American Cryostem) Effective Interest Rate on Debt % : 8.50% (As of Jun. 2022)


View and export this data going back to 2010. Start your Free Trial

What is American Cryostem Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. American Cryostem's annualized positive value of Interest Expense for the quarter that ended in Jun. 2022 was $0.10 Mil. American Cryostem's average total debt for the quarter that ended in Jun. 2022 was $1.18 Mil. Therefore, American Cryostem's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2022 was 8.50%.


American Cryostem Effective Interest Rate on Debt % Historical Data

The historical data trend for American Cryostem's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Effective Interest Rate on Debt % Chart

American Cryostem Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.52 10.12 14.63 31.13 9.89

American Cryostem Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.06 8.88 9.13 8.66 8.50

Competitive Comparison of American Cryostem's Effective Interest Rate on Debt %

For the Biotechnology subindustry, American Cryostem's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Cryostem's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Cryostem's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where American Cryostem's Effective Interest Rate on Debt % falls into.



American Cryostem Effective Interest Rate on Debt % Calculation

American Cryostem's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Sep. 2021 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Sep. 2020 )+Total Debt  (A: Sep. 2021 ))/ count )
=-1  *  -0.104/( (0.952+1.151)/ 2 )
=-1  *  -0.104/1.0515
=9.89 %

where

Total Debt  (A: Sep. 2020 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.108 + 0.844
=0.952

Total Debt  (A: Sep. 2021 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.293 + 0.858
=1.151

American Cryostem's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2022 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Mar. 2022 )+Total Debt  (Q: Jun. 2022 ))/ count )
=-1  *  -0.1/( (1.183+1.169)/ 2 )
=-1  *  -0.1/1.176
=8.50 %

where

Total Debt  (Q: Mar. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.164 + 1.019
=1.183

Total Debt  (Q: Jun. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.151 + 1.018
=1.169

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Jun. 2022) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


American Cryostem  (OTCPK:CRYO) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


American Cryostem Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of American Cryostem's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


American Cryostem (American Cryostem) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724
American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.
Executives
John S Arnone director, officer: Chairman 111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski director, officer: COO 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc. 10 percent owner 188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill 10 percent owner 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina director, 10 percent owner, officer: President and Director 1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915